First Choice Healthcare Solutions, Inc. Liquidation Value

FCHS Medical Laboratories

Cash & Equivalents

$3,859
As of 2026-03-31
Current Price: N/A

Key Metrics

Cash Liquidation Value

Cash minus Total Obligations
Cash: $3,859
Total Obligations: -$48.25M
$-48.25M
Per share: $-1.46
Period: 2026-03-31
incomplete 1 component missing — treated as $0 in formula. Why?
  • Long-Term Debt: not reported in this period (annual-only)

Liquid Liquidation Value

Cash + AR minus Total Obligations
Cash: $3,859
AR: $40,575
Total Obligations: -$48.25M
$-48.21M
Per share: $-1.46
Period: 2026-03-31
incomplete 1 component missing — treated as $0 in formula. Why?
  • Long-Term Debt: not reported in this period (annual-only)

Operating Liquidation Value

Cash + AR + Inventory minus Total Obligations
Cash: $3,859
AR: $40,575
Inventory: N/A
Total Obligations: -$48.25M
$-48.21M
Per share: $-1.46
Period: 2026-03-31
incomplete 2 components missing — treated as $0 in formula. Why?
  • Long-Term Debt: not reported in this period (annual-only)
  • Inventory: not reported

Build your own liquidation scenario

Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.

Open Calculator →

Liquidation Ladder

MetricTotalPer Share
Cash Liquidation Value$-48.25M$-1.46
Liquid Liquidation Value$-48.21M$-1.46
Operating Liquidation Value$-48.21M$-1.46

Key Components (as of 2026-03-31)

Data as of 2026-03-31 from 10-Q filed 2026-05-08. View on SEC EDGAR →

Cash & Equivalents$3,859
Accounts Receivable$40,575
InventoryN/A
Current Liabilities$42.23M
Long-term Debt (?)N/A
Op. Lease Liability (?)$2.80M
Finance Lease (?)N/A
Shares Outstanding33.0M

Explore all 62 XBRL tags and build your own scenario → Open Calculator

Historical

PeriodCashARInventoryAPCurr LiabLT DebtOp LeaseFin Lease
2026-03-31$3,859$40,575N/AN/A$42.23MN/A$2.80MN/A
2025-12-31$5,896$717N/AN/A$40.67MN/A$2.90MN/A
2025-09-30$2,430$1,173N/AN/A$37.16MN/A$2.99MN/A
2025-06-30$6,454$9,459N/AN/A$35.69MN/A$3.08MN/A
2025-03-31$29,645$40,287N/AN/A$34.64MN/A$3.17MN/A
2024-12-31$19,915$72,270N/AN/A$33.27MN/A$3.24MN/A
2024-09-30$1,505$49,201N/AN/A$32.46MN/A$3.46MN/A
2024-06-30$1,516$81,974N/AN/A$31.25MN/A$2.30MN/A

Comments

SEC Filings

PeriodFormFiledLink
2026-03-31 10-Q 2026-05-08 View
2025-12-31 10-K 2026-03-11 View
2025-09-30 10-Q 2025-11-12 View
2025-06-30 10-Q 2025-08-13 View
2025-03-31 10-Q 2025-05-15 View
2024-12-31 10-K 2025-04-15 View
2024-09-30 10-Q 2024-11-13 View
2024-06-30 10-Q 2024-08-14 View

AI Insights

AI Insight·Generated 2026-05-09

First Choice Healthcare Solutions, Inc. (FCHS) presents one of the most adverse liquidation recovery profiles observable in a going-concern filing. As of March 31, 2026, total assets are $4.05M against total liabilities of $45.04M, producing GAAP stockholders' deficit of ($41.0M). Under liquidation haircuts, the asset side deteriorates further: cash of $3,859 recovers at par; accounts receivable of $40,575 at 90-95% yields ~$38K; PP&E net book value of $144K at 50-70% yields ~$72-101K; the right-of-use asset of $3.25M carries zero liquidation value (it extinguishes with the lease obligation but the lease liability of $3.21M remains at face value); deposits of $609K may partially recover but are likely encumbered or landlord-held. Total recoverable assets under liquidation are approximately $0.7-0.8M. Against this, liabilities at face value include: current notes payable of $28.0M (comprised of $20.3M convertible notes -- all classified current, past due -- and $5.3M non-convertible notes current); accounts payable and accrued liabilities of $13.8M (which includes approximately $7.3M in accrued interest on convertible instruments per footnote disclosure); operating lease liability of $3.2M (face value of undiscounted payments $4.1M); and a residual lease settlement liability of approximately $1.2M carried in AP from the 2021 Marina Towers court order. The implied liquidation recovery to equity is deeply negative -- approximately ($44M) -- consistent with MFFAIS CLV of ($45.0M). The debt stack is structurally subordinated against common equity: 10% OID senior secured convertibles ($6.1M principal + $3.9M accrued interest), 35% OID super-priority senior secured convertibles ($10.6M + $3.5M accrued interest), and 20% OID convertibles ($3.6M + $0.7M accrued interest) all hold security interests in company assets. All convertible notes are past due or due within six months and are fully current-classified. Non-convertible notes increased $980K QoQ primarily due to related-party deferred compensation notes to Thor Special Situations LLC (CEO affiliate, $1.71M) and the CEO directly ($426K). Revenue for Q1 2026 was $141 (not a typo -- one hundred forty-one dollars), confirming the company is operationally non-functional. Convertible debt dilution potential is 2.83 billion shares vs. 32.96M shares outstanding -- a 86x overhang that would annihilate any equity recovery even if asset values were materially higher. The filing discloses substantial doubt about going concern. The prior period filing (10-K, December 31, 2025) showed stockholders' deficit of ($39.5M); the Q1 2026 net loss of ($1.44M) deepened the deficit to ($41.0M). No balance sheet line item supports any positive recovery posture for common equity.

Flags

Loading flags...

AI Insight Discussion

Loading...

Community Notes

Loading notes...

Questions

Loading questions...